Peer-reviewed journal articles (257)
  1. 79. Mancilla, V., Decaestecker, C., Ligny, C., Matagne, L., Simon, P., & Courtmans, I. (2010). La surdité moyenne: Étiologie, évaluation linguistique et scolaire. Cahiers de l'audition, 23(3), 5-9.
  2. 80. Pozdzik, A., Berton, A., Schmeiser, H. H., Missoum, W., Decaestecker, C., Salmon, I., Vanherweghem, J.-L., & Nortier, J. (2010). Aristolochic acid nephropathy revisited: a place for innate and adaptive immunity? Histopathology, 56(4), 449-463. doi:10.1111/j.1365-2559.2010.03509.x
  3. 81. Pozdzik, A., Berton, A., Schmeiser, H. H., Missoum, W., Decaestecker, C., Salmon, I., Vanherweghem, J.-L., & Nortier, J. (2010). Aristolochic acid nephropathy revisited: a place for innate and adaptive immunity? Histopathology, 56(4), 449-463. doi:10.1111/j.1365-2559.2010.03509.x
  4. 82. Lamoral-Theys, D., Decaestecker, C., Mathieu, V., Dubois, J., Kornienko, A., Kiss, R., Evidente, A., & Pottier, L. (2010). Lycorine and its derivatives for anticancer drug design. Mini-reviews in medical chemistry, 10(1), 41-50. doi:10.2174/138955710791112604
  5. 83. Lamoral-Theys, D., Le Mercier, M., Le Calve, B., Rynkowski, M., Bruyère, C., Decaestecker, C., Haibe-Kains, B., Bontempi, G., Dubois, J., Lefranc, F., & Kiss, R. (2010). Long-term temozolomide treatment induces marked amino metabolism modifications and an increase in TMZ sensitivity in Hs683 oligodendroglioma cells. Neoplasia (New York, N.Y.), 12(1), 69-79. doi:10.1593/neo.91360
  6. 84. Wauthoz, N., Deleuze, P., Hecq, J., Roland, I., Saussez, S., Adanja, I., Debeir, O., Decaestecker, C., Mathieu, V., Kiss, R., & Amighi, K. (2010). In vivo assessment of temozolomide local delivery for lung cancer inhalation therapy. European journal of pharmaceutical sciences, 39, 402-411. doi:10.1016/j.ejps.2010.01.010
  7. 85. Adanja, I., Debeir, O., Megalizzi, V., Kiss, R., Warzée, N., & Decaestecker, C. (2010). Automated tracking of unmarked cells migrating in three-dimensional matrices applied to anti-cancer drug screening. Experimental cell research, 316(2), 181-193. doi:10.1016/j.yexcr.2009.10.004
  8. 86. Cludts, S., Decaestecker, C., Mahillon, V., Chevalier, D., Kaltner, H., André, S., Remmelink, M., Leroy, X., Gabius, H.-J., & Saussez, S. (2009). Galectin-8 up-regulation during hypopharyngeal and laryngeal tumor progression and comparison with galectin-1, -3 and -7. Anticancer research, 29(12), 4933-4940.
  9. 87. Megalizzi, V., Decaestecker, C., Debeir, O., Spiegl-Kreinecker, S., Berger, W., Lefranc, F., Kast, R. E., & Kiss, R. (2009). Screening of anti-glioma effects induced by sigma-1 receptor ligands: potential new use for old anti-psychiatric medicines. European journal of cancer, 45(16), 2893-2905. doi:10.1016/j.ejca.2009.07.011
  10. 88. Leyman, S., Sidani, M., Ritsma, L., Waterschoot, D., Eddy, R., Dewitte, D., Debeir, O., Decaestecker, C., Vandekerckhove, J., van Rheenen, J., Ampe, C., Condeelis, J., & Van Troys, M. (2009). Unbalancing the phosphatidylinositol-4,5-bisphosphate-cofilin interaction impairs cell steering. Molecular biology of the cell, 20(21), 4509-4523. doi:10.1091/mbc.E09-02-0121
  11. 89. Decaestecker, C., Moles Lopez, X., D'Haene, N., Roland, I., Guendouz, S., Duponchelle, C., Berton, A., Debeir, O., & Salmon, I. (2009). Requirements for the valid quantification of immunostains on tissue microarray materials using image analysis. Proteomics, 9(19), 4478-4494. doi:10.1002/pmic.200800936
  12. 90. Mathieu, A., Weynand, B., Verbeken, E., Da Silva, S., Decaestecker, C., Salmon, I., & Demetter, P. (2009). Comparison of four antibodies for immunohistochemical evaluation of epidermal growth factor receptor expression in non-small cell lung cancer. Lung cancer, 1301, 152-162. doi:10.1016/j.lungcan.2009.09.003
  13. 91. Capouillez, A., Debauve, G., Decaestecker, C., Filleul, O., Chevalier, D., Mortuaire, G., Coppée, F., Leroy, X., Belayew, A., & Saussez, S. (2009). The helicase-like transcription factor is a strong predictor of recurrence in hypopharyngeal but not in laryngeal squamous cell carcinomas. Histopathology, 55(1), 77-90. doi:10.1111/j.1365-2559.2009.03330.x
  14. 92. Lefranc, F., Sauvage, S., Van Goietsenoven, G., Megalizzi, V., Lamoral-Theys, D., Debeir, O., Spiegl-Kreinecker, S., Berger, W., Mathieu, V., Decaestecker, C., & Kiss, R. (2009). Narciclasine, a plant growth modulator, activates Rho and stress fibers in glioblastoma cells. Molecular cancer therapeutics, 8(7), 1739-1750. doi:10.1158/1535-7163.MCT-08-0932
  15. 93. Marechal, R., Demetter, P., Nagy, N., Berton, A., Decaestecker, C., Polus, M., Closset, J., Devière, J., Salmon, I., & Van Laethem, J.-L. (2009). High expression of CXCR4 may predict poor survival in resected pancreatic adenocarcinoma. British Journal of Cancer, 100(9), 1444-1451. doi:10.1038/sj.bjc.6605020
  16. 94. Le Mercier, M., Fortin, S., Mathieu, V., Roland, I., Spiegl-Kreinecker, S., Haibe-Kains, B., Bontempi, G., Decaestecker, C., Berger, W., Lefranc, F., & Kiss, R. (2009). Galectin 1 proangiogenic and promigratory effects in the Hs683 oligodendroglioma model are partly mediated through the control of BEX2 expression. Neoplasia (New York, N.Y.), 11(5), 485-496.
  17. 95. Saussez, S., Cludts, S., Capouillez, A., Mortuaire, G., Smetana, K., Kaltner, H., André, S., Leroy, X., Gabius, H.-J., & Decaestecker, C. (2009). Identification of matrix metalloproteinase-9 as an independent prognostic marker in laryngeal and hypopharyngeal cancer with opposite correlations to adhesion/growth-regulatory galectins-1 and -7. International journal of oncology, 34(2), 433-439. doi:10.3892/ijo_00000167
  18. 96. Yen, L., Fouss, F., Decaestecker, C., Francq, P., & Saerens, M. (2009). Graph nodes clustering with the sigmoid commute-time kernel: a comparative study. Data & knowledge engineering, 68(3), 338-361.
  19. 97. Saussez, S., Decaestecker, C., Cludts, S., Ernoux-Neufcoeur, P., Chevalier, D., Smetana Jr., K., André, S., Leroy, X., & Gabius, H.-J. (2009). Adhesion/growth-regulatory tissue lectin galectin-1 in relation to angiogenesis/lymphocyte infiltration and prognostic relevance of stromal up-regulation in laryngeal carcinomas. Anticancer research, 29(1), 59-65.
  20. 98. Mathieu, A., Nagy, N., Decaestecker, C., Ferdinande, L., Vandenbroucke, K., Rottiers, P., Cuvelier, C. A., Salmon, I., & Demetter, P. (2008). Expression of galectins-1, -3 and -4 varies with strain and type of experimental colitis in mice. International journal of experimental pathology, 89(6), 438-446. doi:10.1111/j.1365-2613.2008.00598.x
    21. << Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 Next >>